IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

PCI Synthesis appoints new v.p./business development

8:12 AM MDT | October 7, 2013 | Deepti Ramesh

PCI Synthesis (Newburyport, MA), a custom chemical manufacturer of new chemical entities (NCE), generic active pharmaceutical ingredients (APIs), complex pharmaceutical intermediates, and other specialty products, says it has appointed Glenn Killingworth as v.p./business development. A specialist in the field of organic chemistry, Killingworth brings 25 years of experience working for specialist companies, including former Fisher Scientific, Peakdale Molecular (High Peak, UK), Almac Sciences (Craigavon, UK), WuXi Apptec (Shanghai), and Asymchem (Morrisville, NC)...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa